Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7074798 Xanthine derivative and DPPIV inhibitor

Patent 7074798 was granted and assigned to Eisai on July, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Eisai

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

70747980

Patent Inventor Names

Tadashi Nagakura0

Mika Aoki0

Eita Emori0

Fumiyoshi Matsuura0

Hironori Ikuta0

Kazuto Yamazaki0

Nobuyuki Yasuda0

Richard Clark0

...

Date of Patent

July 11, 2006

Patent Application Number

103749180

Date Filed

February 24, 2003

Patent Citations Received

‌

US Patent 11919903 Polymorphs

‌

US Patent 11911387 Vasoprotective and cardioprotective antidiabetic therapy

‌

US Patent 11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

Patent Primary Examiner

‌

Mark L. Berch

Patent abstract

The present invention provides novel compounds exhibiting an excellent DPPIV inhibition effect.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7074798 Xanthine derivative and DPPIV inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API